This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

Industry insights seminar

12.00-13.00

Webinar

Part of a series of seminars featuring selected industry speakers, this time including Dr Bill Haynes of Novo Nordisk.

Topic: A multi-omics approach for type 2 diabetes target discovery: identification and characterisation of disease-specific small open reading frame encoded peptides.

Sponsored by the University of Oxford BioEscalator.

Further information and booking details here.